HK1021372A1 - Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists - Google Patents

Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Info

Publication number: HK1021372A1
Authority: HK; Hong Kong
Prior art keywords: acylaminoalkenylene; antagonists; amide derivatives; amide; derivatives
Prior art date: 1996-08-22

Application number

HK99106019A

Other languages

English (en)

Inventor

Marc Gerspacher

Sprecher Andreas Von

Robert Mah

Silvio Roggo

Stefan Stutz

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-22

Filing date

1999-12-21

Publication date

2000-06-09

1999-12-21 Application filed by Novartis Ag filed Critical Novartis Ag

2000-06-09 Publication of HK1021372A1 publication Critical patent/HK1021372A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HK99106019A 1996-08-22 1999-12-21 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists HK1021372A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH206196		1996-08-22
PCT/EP1997/004436 WO1998007694A1 (en)	1996-08-22	1997-08-13	Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Publications (1)

Publication Number	Publication Date
HK1021372A1 true HK1021372A1 (en)	2000-06-09

Family

ID=4225003

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK99106019A HK1021372A1 (en)	1996-08-22	1999-12-21	Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists

Country Status (32)

Country	Link
US (1)	US6319917B1 (xx)
EP (1)	EP0923550B1 (xx)
JP (1)	JP3654908B2 (xx)
KR (1)	KR100467402B1 (xx)
CN (1)	CN1119328C (xx)
AR (1)	AR009266A1 (xx)
AT (1)	ATE224875T1 (xx)
AU (1)	AU721850B2 (xx)
BR (1)	BR9711350A (xx)
CA (1)	CA2264065C (xx)
CO (1)	CO4900047A1 (xx)
CZ (1)	CZ294233B6 (xx)
DE (1)	DE69715886T2 (xx)
DK (1)	DK0923550T3 (xx)
ES (1)	ES2184083T3 (xx)
HK (1)	HK1021372A1 (xx)
HU (1)	HU226395B1 (xx)
ID (1)	ID18059A (xx)
IL (1)	IL128631A (xx)
MY (1)	MY132550A (xx)
NO (1)	NO312292B1 (xx)
NZ (1)	NZ334736A (xx)
PE (1)	PE107498A1 (xx)
PL (1)	PL193731B1 (xx)
PT (1)	PT923550E (xx)
RU (1)	RU2185375C2 (xx)
SI (1)	SI0923550T1 (xx)
SK (1)	SK283991B6 (xx)
TR (1)	TR199900363T2 (xx)
TW (1)	TW438777B (xx)
WO (1)	WO1998007694A1 (xx)
ZA (1)	ZA977493B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6281300B1 (en) *	1998-03-20	2001-08-28	Exxon Chemical Patents, Inc.	Continuous slurry polymerization volatile removal
GB0010958D0 (en) *	2000-05-05	2000-06-28	Novartis Ag	Organic compounds
GB0203061D0 (en) *	2002-02-08	2002-03-27	Novartis Ag	Organic compounds
GB0224788D0 (en) *	2002-10-24	2002-12-04	Novartis Ag	Organic compounds
GB2394417A (en) *	2002-10-24	2004-04-28	Novartis Ag	Solid dispersion comprising a piperidine substance P antagonist and a carrier
BRPI0415923A (pt) *	2003-10-27	2006-12-26	Novartis Ag	uso de antagonistas de neuroquinina no tratamento de incontigência urinária
CN103393691A (zh) *	2003-12-01	2013-11-20	剑桥企业有限公司	抗炎药
GB0402679D0 (en) *	2004-02-06	2004-03-10	Novartis Ag	Organic compounds
JO2630B1 (en)	2006-04-13	2012-06-17	نوفارتيس ايه جي	Organic compounds
GB0607532D0 (en) *	2006-04-13	2006-05-24	Novartis Ag	Organic compounds
EP1938804A1 (en) *	2006-12-22	2008-07-02	Novartis AG	Pharmaceutical formulation comprising neurokinin antagonist
JP2010516731A (ja)	2007-01-24	2010-05-20	グラクソグループリミテッド	２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
MX2011008878A (es) *	2009-02-24	2011-09-21	Novartis Ag	Usos de antagonistas de los receptores de nk.
RU2697414C1 (ru) *	2018-05-11	2019-08-14	Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс"	Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2110514A1 (en)	1991-07-05	1993-01-21	Raymond Baker	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) *	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
US5217996A (en)	1992-01-22	1993-06-08	Ciba-Geigy Corporation	Biaryl substituted 4-amino-butyric acid amides
EP0716077A1 (de) *	1994-12-08	1996-06-12	Ciba-Geigy Ag	Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
NZ300942A (en)	1995-02-22	1998-12-23	Novartis Ag	1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists

1997
- 1997-08-08 MY MYPI97003625A patent/MY132550A/en unknown
- 1997-08-13 PT PT97918984T patent/PT923550E/pt unknown
- 1997-08-13 AT AT97918984T patent/ATE224875T1/de active
- 1997-08-13 RU RU99106157/04A patent/RU2185375C2/ru not_active IP Right Cessation
- 1997-08-13 DK DK97918984T patent/DK0923550T3/da active
- 1997-08-13 CN CN97198633A patent/CN1119328C/zh not_active Expired - Fee Related
- 1997-08-13 BR BR9711350A patent/BR9711350A/pt not_active IP Right Cessation
- 1997-08-13 CA CA002264065A patent/CA2264065C/en not_active Expired - Fee Related
- 1997-08-13 DE DE69715886T patent/DE69715886T2/de not_active Expired - Lifetime
- 1997-08-13 WO PCT/EP1997/004436 patent/WO1998007694A1/en active IP Right Grant
- 1997-08-13 CZ CZ1999581A patent/CZ294233B6/cs not_active IP Right Cessation
- 1997-08-13 TR TR1999/00363T patent/TR199900363T2/xx unknown
- 1997-08-13 ES ES97918984T patent/ES2184083T3/es not_active Expired - Lifetime
- 1997-08-13 SI SI9730413T patent/SI0923550T1/xx unknown
- 1997-08-13 SK SK221-99A patent/SK283991B6/sk not_active IP Right Cessation
- 1997-08-13 KR KR10-1999-7001487A patent/KR100467402B1/ko not_active IP Right Cessation
- 1997-08-13 AU AU42993/97A patent/AU721850B2/en not_active Ceased
- 1997-08-13 HU HU0001165A patent/HU226395B1/hu not_active IP Right Cessation
- 1997-08-13 JP JP51037198A patent/JP3654908B2/ja not_active Expired - Lifetime
- 1997-08-13 NZ NZ334736A patent/NZ334736A/xx not_active IP Right Cessation
- 1997-08-13 IL IL12863197A patent/IL128631A/en not_active IP Right Cessation
- 1997-08-13 EP EP97918984A patent/EP0923550B1/en not_active Expired - Lifetime
- 1997-08-19 AR ARP970103747A patent/AR009266A1/es active IP Right Grant
- 1997-08-20 ID IDP972913A patent/ID18059A/id unknown
- 1997-08-20 PE PE1997000741A patent/PE107498A1/es not_active Application Discontinuation
- 1997-08-21 CO CO97048265A patent/CO4900047A1/es unknown
- 1997-08-21 ZA ZA977493A patent/ZA977493B/xx unknown
- 1997-08-22 TW TW086111854A patent/TW438777B/zh not_active IP Right Cessation
1999
- 1999-02-19 PL PL97331740A patent/PL193731B1/pl not_active IP Right Cessation
- 1999-02-19 NO NO19990786A patent/NO312292B1/no not_active IP Right Cessation
- 1999-12-21 HK HK99106019A patent/HK1021372A1/xx not_active IP Right Cessation
2000
- 2000-09-05 US US09/655,170 patent/US6319917B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU721850B2 (en)	2000-07-13
EP0923550A1 (en)	1999-06-23
US6319917B1 (en)	2001-11-20
NO312292B1 (no)	2002-04-22
HUP0001165A3 (en)	2002-02-28
MY132550A (en)	2007-10-31
HUP0001165A2 (hu)	2000-11-28
DE69715886T2 (de)	2003-05-15
KR20000068325A (ko)	2000-11-25
NO990786D0 (no)	1999-02-19
AR009266A1 (es)	2000-04-12
KR100467402B1 (ko)	2005-01-24
PE107498A1 (es)	1999-01-28
DE69715886D1 (de)	2002-10-31
ID18059A (id)	1998-02-26
CA2264065A1 (en)	1998-02-26
SK22199A3 (en)	2000-02-14
CO4900047A1 (es)	2000-03-27
ES2184083T3 (es)	2003-04-01
CZ58199A3 (cs)	1999-06-16
JP2001503387A (ja)	2001-03-13
ZA977493B (en)	1998-08-03
WO1998007694A1 (en)	1998-02-26
NO990786L (no)	1999-03-25
ATE224875T1 (de)	2002-10-15
SI0923550T1 (en)	2003-02-28
AU4299397A (en)	1998-03-06
RU2185375C2 (ru)	2002-07-20
TR199900363T2 (xx)	1999-04-21
NZ334736A (en)	2000-09-29
PL193731B1 (pl)	2007-03-30
CN1119328C (zh)	2003-08-27
IL128631A (en)	2002-09-12
TW438777B (en)	2001-06-07
SK283991B6 (sk)	2004-07-07
IL128631A0 (en)	2000-01-31
JP3654908B2 (ja)	2005-06-02
CN1233238A (zh)	1999-10-27
BR9711350A (pt)	1999-08-17
CZ294233B6 (cs)	2004-11-10
EP0923550B1 (en)	2002-09-25
CA2264065C (en)	2008-02-05
PL331740A1 (en)	1999-08-02
PT923550E (pt)	2003-01-31
HU226395B1 (en)	2008-11-28
DK0923550T3 (da)	2003-01-06

Publication	Publication Date	Title
HK1003884A1 (en)	1998-11-13	Quinoline derivatives as tachykinin nk3 receptor and antagonists
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
GB9625020D0 (en)	1997-01-15	Network restoration
HK1020045A1 (en)	2000-03-10	Benzothiopenecarboxamide derivatives and pgd2 antagonists comprising them
CY2505B1 (en)	2005-12-23	Quinoline derivatives as nk3 antagonists
ZA97209B (en)	1998-07-10	Substituted aza- and diacycloheptane and -cyclooctane compounds and their use
GB9625843D0 (en)	1997-01-29	Phenyl spiroethercycloalkyl tachykinn receptor antagonists
EP0885205A4 (en)	2002-11-27	FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0885213A4 (en)	1999-04-28	FIBRINOGEN RECEPTOR ANTAGONISTS
HU9601176D0 (en)	1996-06-28	Adhesion-receptor antagonists
IL128631A0 (en)	2000-01-31	Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
IL129096A0 (en)	2000-02-17	Substituted heterocycles as anti-tumor agents
EP0796098A4 (en)	1998-04-29	FIBRINOGEN RECEPTOR ANTAGONISTS
HU9503191D0 (en)	1996-01-29	Adhesion-receptor antagonists
PL330708A1 (en)	1999-05-24	Derivatives of indolydine useful as antagonists of 5-ht-2c receptor
PL333079A1 (en)	1999-11-08	Piparazinic derivatives as antagonists of neurokinin
EP0941111A4 (en)	2000-09-27	HEPATOCYTE GROWTH FACTOR ANTAGONISTS
EP0800395A4 (en)	1998-04-29	FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0781133A4 (en)	1997-12-10	FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0928194A4 (en)	2001-01-17	COMPOSITIONS AND METHODS FOR ADMINISTERING INTEGRIN RECEPTOR ANTAGONISTS
EP0957908A4 (en)	2003-03-12	FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9708766D0 (en)	1997-06-25	Fibrinogen receptor antagonist
GB9621902D0 (en)	1996-12-11	Neurotrophin antagonist compositions
GB9626308D0 (en)	1997-02-05	av›3 antagonists
TW315661U (en)	1997-09-11	Cylinder chair

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2013-03-08	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20120813